Trump’s 200% tariffs on pharma: Why India’s generic medicines could still remain competitive

US President Donald Trump on Tuesday announced the final stage of his pharmaceutical tariff plan, under which imported generic medicines will continue to enter the US without duties until August 1, 2028.

First seen 2h ago · latest update 2h ago · India · politics

Developing: this story surfaced recently from a single outlet. It appears early by design — expect the confidence score to move as more outlets report (or don’t).